Kineticos

A specialized management consulting firm serving the life science industry

[Kineticos @Kineticos]

New approaches in artificial intelligence have created powerful tools for discovering antibiotics.

#AMR #antimicrobialresistance #antibiotics #AI #drugdiscovery

https://t.co/JGvPdsWFul

[Kineticos @Kineticos]

Rising antibiotic resistance rates in Ukraine show that AMR is not a regional issue. The threat of AMR, both medically and economically, is increasing worldwide.

#AMR #AMRpolicy #antimicrobialresistance

https://t.co/mBhUuRN8VU

[Kineticos @Kineticos]

This article dives into the emerging field of digital antibiotic discovery, and it's potential to combat antimicrobial resistance.

#AMR #AntimicrobialResistance

https://t.co/IGBxlHkau5

[Kineticos @Kineticos]

Phage therapy has come a long way since Western Countries dropped the treatment after the discovery of penicillin.

#AMR #AntimicrobialResistance

https://t.co/GXrJFHIX2G

[Kineticos @Kineticos]

Bacteriophage, or phage, therapy offers a promising solution to hard-to-treat chronic infections like those found in cystic fibrosis (CF) patients.

#antimicrobialresistance #lifesciences #biotechnology #AMR

https://t.co/2V3IyZ11W3

[Kineticos @Kineticos]

Researchers from the University of Pittsburgh have found a way to engineer custom T-cell therapies more efficiently. The researchers engineered T cells with receptors containing an enzyme called SNAPtag.

#biotechnology #lifesciences #celltherapy

https://t.co/n872BTqmeZ

[Kineticos @Kineticos]

UC Davis Health researchers are conducting a trial to investigate using duoCAR T-cell therapy to treat HIV. This is yet another example of CAR-T cell therapy branching out from oncology.

#biotechnology #lifesciences #celltherapy #HIV

https://t.co/tmve0Q9tI5

[Kineticos @Kineticos]

Kineticos has found that hiring top talent who can transition to engaged and competent employees is critical to success.

Click the link below to learn the steps for hiring the right employee.

#biotechnology #lifesciences

https://t.co/ZLERoWeA02

[Kineticos @Kineticos]

Verismo Therapeutics recently announced it had received Fast Track designation from the FDA for its investigational new drug, SynKIR-110, for treating patients with mesothelioma.

#biotechnology #lifesciences #celltherapy #cellandgenetherapy

https://t.co/cgTWqQDBIi

[Kineticos @Kineticos]

@immunebridge, an NK cell therapy biotech, recently closed out a $12M financing round led by M ventures and Insight Partners to help advance their novel NK Cell therapies.

#biotechnology #lifesciences #celltherapy

Click the link to learn more: https://t.co/Oz5Mu8WdCc

[Kineticos @Kineticos]

Click the link below to learn more about attracting, developing, and maintaining the right employees to propel your business into the future.

#biotechnology #lifesciences

https://t.co/cyxf1ulsEJ

[Kineticos @Kineticos]

CTRL Therapeutics, a company extracting circulating tumor-reactive lymphocytes (cTRLs) from blood to improve cell therapies, announced a $10M seed financing led by General Catalyst with participation from others.
#biotechnology #lifesciences #celltherapy

https://t.co/SYd343nCKw

[Kineticos @Kineticos]

@CaribouBio was recently granted fast-track designation for CB-011, an allogeneic CAR-T cell therapy for relapsed or refractory multiple myeloma.

Thanks to @CrisprMedicine for the great article.

#biotechnology #lifesciences #celltherapy

https://t.co/rZ3qNIpF2E

[Kineticos @Kineticos]

Here we provide a guide on conducting a rigorous, blinded pricing study of current clients and prospects to uncover hidden areas where prices may be more sensitive and inelastic than currently perceived.

#biotechnology #lifesciences

https://t.co/8M3gG61d7s

[Kineticos @Kineticos]

@CabalettaBio announced that the FDA cleared their IND application to start a trial of lupus therapy CABA-201, a 4-1BB-containing fully human CD19-CAR T cell investigational therapy.

#biotechnology #lifesciences #celltherapy #cellandgenetherapy

https://t.co/p7Rambvns1

[Kineticos @Kineticos]

RNA therapeutics could potentially remedy the problem of undruggable proteins. RNA can target any gene of interest by targeting a specific nucleotide sequence.

Click the link below to learn more.

#lifesciences #biotechnology #rnatherapeutics

https://t.co/MVBsiTk3mH

[Kineticos @Kineticos]

Click the link below to learn more about the barriers preventing oncolytic viruses from advancing.

#lifesciences #biotechnology #oncolyticvirus

https://t.co/oIaWzMiODW

[Kineticos @Kineticos]

Click the link below to learn more about the emerging field of oncolytic viruses.

#lifesciences #biotechnology #oncolyticvirus

https://t.co/GuMNN4EPfw

[Kineticos @Kineticos]

While most cell therapy research is oncology-focused, there has been an uptick in products targeting other therapeutic areas. Rinri Therapeutics focuses on hearing loss.

#biotechnology #lifesciences #celltherapy #cellandgenetherapy

https://t.co/V9g5lUMYME

[Kineticos @Kineticos]

Sonoma biotherapeutics and Regeneron announced a collaboration to combine their respective scientific expertise and technology platforms.

#biotechnology #lifesciences #celltherapy #cellandgenetherapy

https://t.co/7qtFXo5mwY https://t.co/a0mx9J3Qbv